| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.35 | 7e-10 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-08 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.27 | 5e-07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.26 | 2e-06 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 5e-05 |